4.5 Article

Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis

Journal

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 23, Issue 5, Pages 3451-3463

Publisher

WILEY
DOI: 10.1111/jcmm.14241

Keywords

breast cancer; G6PD; HIF-1 alpha; Notch1; Nrf2

Funding

  1. practical training plan for the cross training of high level talents in Beijing Universities [2017271]
  2. National Natural Sciences Foundation of China [30800580]
  3. National Laboratory of Biomacromolecules [2017kf02]
  4. Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CIT TCD201304054]
  5. Open Project of Key Laboratory of Genomics and Precision Medicine, Chinese Academy of Sciences

Ask authors/readers for more resources

Abnormal metabolism of tumour cells is closely related to the occurrence and development of breast cancer, during which the expression of NF-E2-related factor 2 (Nrf2) is of great significance. Metastatic breast cancer is one of the most common causes of cancer death worldwide; however, the molecular mechanism underlying breast cancer metastasis remains unknown. In this study, we found that the overexpression of Nrf2 promoted proliferation and migration of breast cancers cells. Inhibition of Nrf2 and overexpression of Kelch-like ECH-associated protein 1 (Keap1) reduced the expression of glucose-6-phosphate dehydrogenase (G6PD) and transketolase of pentose phosphate pathway, and overexpression of Nrf2 and knockdown of Keap1 had opposite effects. Our results further showed that the overexpression of Nrf2 promoted the expression of G6PD and Hypoxia-inducing factor 1 alpha (HIF-1 alpha) in MCF-7 and MDA-MB-231 cells. Overexpression of Nrf2 up-regulated the expression of Notch1 via G6PD/HIF-1 alpha pathway. Notch signalling pathway affected the proliferation of breast cancer by affecting its downstream gene HES-1, and regulated the migration of breast cancer cells by affecting the expression of EMT pathway. The results suggest that Nrf2 is a potential molecular target for the treatment of breast cancer and targeting Notch1 signalling pathway may provide a promising strategy for the treatment of Nrf2-driven breast cancer metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available